A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...
BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback